These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27732966)

  • 1. HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer.
    Ross-Adams H; Ball S; Lawrenson K; Halim S; Russell R; Wells C; Strand SH; Ørntoft TF; Larson M; Armasu S; Massie CE; Asim M; Mortensen MM; Borre M; Woodfine K; Warren AY; Lamb AD; Kay J; Whitaker H; Ramos-Montoya A; Murrell A; Sørensen KD; Fridley BL; Goode EL; Gayther SA; Masters J; Neal DE; Mills IG
    Oncotarget; 2016 Nov; 7(46):74734-74746. PubMed ID: 27732966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.
    Shen H; Fridley BL; Song H; Lawrenson K; Cunningham JM; Ramus SJ; Cicek MS; Tyrer J; Stram D; Larson MC; Köbel M; ; Ziogas A; Zheng W; Yang HP; Wu AH; Wozniak EL; Woo YL; Winterhoff B; Wik E; Whittemore AS; Wentzensen N; Weber RP; Vitonis AF; Vincent D; Vierkant RA; Vergote I; Van Den Berg D; Van Altena AM; Tworoger SS; Thompson PJ; Tessier DC; Terry KL; Teo SH; Templeman C; Stram DO; Southey MC; Sieh W; Siddiqui N; Shvetsov YB; Shu XO; Shridhar V; Wang-Gohrke S; Severi G; Schwaab I; Salvesen HB; Rzepecka IK; Runnebaum IB; Rossing MA; Rodriguez-Rodriguez L; Risch HA; Renner SP; Poole EM; Pike MC; Phelan CM; Pelttari LM; Pejovic T; Paul J; Orlow I; Omar SZ; Olson SH; Odunsi K; Nickels S; Nevanlinna H; Ness RB; Narod SA; Nakanishi T; Moysich KB; Monteiro AN; Moes-Sosnowska J; Modugno F; Menon U; McLaughlin JR; McGuire V; Matsuo K; Adenan NA; Massuger LF; Lurie G; Lundvall L; Lubiński J; Lissowska J; Levine DA; Leminen A; Lee AW; Le ND; Lambrechts S; Lambrechts D; Kupryjanczyk J; Krakstad C; Konecny GE; Kjaer SK; Kiemeney LA; Kelemen LE; Keeney GL; Karlan BY; Karevan R; Kalli KR; Kajiyama H; Ji BT; Jensen A; Jakubowska A; Iversen E; Hosono S; Høgdall CK; Høgdall E; Hoatlin M; Hillemanns P; Heitz F; Hein R; Harter P; Halle MK; Hall P; Gronwald J; Gore M; Goodman MT; Giles GG; Gentry-Maharaj A; Garcia-Closas M; Flanagan JM; Fasching PA; Ekici AB; Edwards R; Eccles D; Easton DF; Dürst M; du Bois A; Dörk T; Doherty JA; Despierre E; Dansonka-Mieszkowska A; Cybulski C; Cramer DW; Cook LS; Chen X; Charbonneau B; Chang-Claude J; Campbell I; Butzow R; Bunker CH; Brueggmann D; Brown R; Brooks-Wilson A; Brinton LA; Bogdanova N; Block MS; Benjamin E; Beesley J; Beckmann MW; Bandera EV; Baglietto L; Bacot F; Armasu SM; Antonenkova N; Anton-Culver H; Aben KK; Liang D; Wu X; Lu K; Hildebrandt MA; ; ; Schildkraut JM; Sellers TA; Huntsman D; Berchuck A; Chenevix-Trench G; Gayther SA; Pharoah PD; Laird PW; Goode EL; Pearce CL
    Nat Commun; 2013; 4():1628. PubMed ID: 23535649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk.
    Painter JN; O'Mara TA; Batra J; Cheng T; Lose FA; Dennis J; Michailidou K; Tyrer JP; Ahmed S; Ferguson K; Healey CS; Kaufmann S; Hillman KM; Walpole C; Moya L; Pollock P; Jones A; Howarth K; Martin L; Gorman M; Hodgson S; ; ; De Polanco MM; Sans M; Carracedo A; Castellvi-Bel S; Rojas-Martinez A; Santos E; Teixeira MR; Carvajal-Carmona L; Shu XO; Long J; Zheng W; Xiang YB; ; Montgomery GW; Webb PM; Scott RJ; McEvoy M; Attia J; Holliday E; Martin NG; Nyholt DR; Henders AK; Fasching PA; Hein A; Beckmann MW; Renner SP; Dörk T; Hillemanns P; Dürst M; Runnebaum I; Lambrechts D; Coenegrachts L; Schrauwen S; Amant F; Winterhoff B; Dowdy SC; Goode EL; Teoman A; Salvesen HB; Trovik J; Njolstad TS; Werner HM; Ashton K; Proietto T; Otton G; Tzortzatos G; Mints M; Tham E; ; Hall P; Czene K; Liu J; Li J; Hopper JL; Southey MC; ; Ekici AB; Ruebner M; Johnson N; Peto J; Burwinkel B; Marme F; Brenner H; Dieffenbach AK; Meindl A; Brauch H; ; Lindblom A; Depreeuw J; Moisse M; Chang-Claude J; Rudolph A; Couch FJ; Olson JE; Giles GG; Bruinsma F; Cunningham JM; Fridley BL; Børresen-Dale AL; Kristensen VN; Cox A; Swerdlow AJ; Orr N; Bolla MK; Wang Q; Weber RP; Chen Z; Shah M; French JD; Pharoah PD; Dunning AM; Tomlinson I; Easton DF; Edwards SL; Thompson DJ; Spurdle AB
    Hum Mol Genet; 2015 Mar; 24(5):1478-92. PubMed ID: 25378557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-Generation Sequencing Approach in Methylation Analysis of HNF1B and GATA4 Genes: Searching for Biomarkers in Ovarian Cancer.
    Bubancova I; Kovarikova H; Laco J; Ruszova E; Dvorak O; Palicka V; Chmelarova M
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HNF1B and JAZF1 genes, diabetes, and prostate cancer risk.
    Stevens VL; Ahn J; Sun J; Jacobs EJ; Moore SC; Patel AV; Berndt SI; Albanes D; Hayes RB
    Prostate; 2010 May; 70(6):601-7. PubMed ID: 19998368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HNF1B-mediated repression of SLUG is suppressed by EZH2 in aggressive prostate cancer.
    Wang J; He C; Gao P; Wang S; Lv R; Zhou H; Zhou Q; Zhang K; Sun J; Fan C; Ding G; Lan F
    Oncogene; 2020 Feb; 39(6):1335-1346. PubMed ID: 31636385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale fine mapping of the HNF1B locus and prostate cancer risk.
    Berndt SI; Sampson J; Yeager M; Jacobs KB; Wang Z; Hutchinson A; Chung C; Orr N; Wacholder S; Chatterjee N; Yu K; Kraft P; Feigelson HS; Thun MJ; Diver WR; Albanes D; Virtamo J; Weinstein S; Schumacher FR; Cancel-Tassin G; Cussenot O; Valeri A; Andriole GL; Crawford ED; Haiman C; Henderson B; Kolonel L; Le Marchand L; Siddiq A; Riboli E; Travis RC; Kaaks R; Isaacs W; Isaacs S; Wiley KE; Gronberg H; Wiklund F; Stattin P; Xu J; Zheng SL; Sun J; Vatten LJ; Hveem K; Njølstad I; Gerhard DS; Tucker M; Hayes RB; Hoover RN; Fraumeni JF; Hunter DJ; Thomas G; Chanock SJ
    Hum Mol Genet; 2011 Aug; 20(16):3322-9. PubMed ID: 21576123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cumulative evidence for relationships between multiple variants of HNF1B and the risk of prostate and endometrial cancers.
    Tong Y; Qu Y; Li S; Zhao F; Wang Y; Mu D
    BMC Med Genet; 2018 Jul; 19(1):128. PubMed ID: 30053805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in LMTK2, MSMB and HNF1B gene expression are associated with the development of prostate cancer.
    Harries LW; Perry JR; McCullagh P; Crundwell M
    BMC Cancer; 2010 Jun; 10():315. PubMed ID: 20569440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HNF1B, EZH2 and ECI2 in prostate carcinoma. Molecular, immunohistochemical and clinico-pathological study.
    Dundr P; Bártů M; Hojný J; Michálková R; Hájková N; Stružinská I; Krkavcová E; Hadravský L; Kleissnerová L; Kopejsková J; Hiep BQ; Němejcová K; Jakša R; Čapoun O; Řezáč J; Jirsová K; Franková V
    Sci Rep; 2020 Sep; 10(1):14365. PubMed ID: 32873863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HNF1B inhibits cell proliferation via repression of SMAD6 expression in prostate cancer.
    Lu W; Sun J; Zhou H; Wang F; Zhao C; Li K; Fan C; Ding G; Wang J
    J Cell Mol Med; 2020 Dec; 24(24):14539-14548. PubMed ID: 33174391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative bioinformatics links HNF1B with clear cell carcinoma and tumor-associated thrombosis.
    Cuff J; Salari K; Clarke N; Esheba GE; Forster AD; Huang S; West RB; Higgins JP; Longacre TA; Pollack JR
    PLoS One; 2013; 8(9):e74562. PubMed ID: 24040285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12.
    Sun J; Zheng SL; Wiklund F; Isaacs SD; Purcell LD; Gao Z; Hsu FC; Kim ST; Liu W; Zhu Y; Stattin P; Adami HO; Wiley KE; Dimitrov L; Sun J; Li T; Turner AR; Adams TS; Adolfsson J; Johansson JE; Lowey J; Trock BJ; Partin AW; Walsh PC; Trent JM; Duggan D; Carpten J; Chang BL; Grönberg H; Isaacs WB; Xu J
    Nat Genet; 2008 Oct; 40(10):1153-5. PubMed ID: 18758462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HNF1B polymorphism associated with development of prostate cancer in Korean patients.
    Kim HJ; Bae JS; Lee J; Chang IH; Kim KD; Shin HD; Han JH; Lee SY; Kim W; Myung SC
    Urology; 2011 Oct; 78(4):969.e1-6. PubMed ID: 21982019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of association of HNF1B variants with diverse cancers: collaborative analysis of data from 19 genome-wide association studies.
    Elliott KS; Zeggini E; McCarthy MI; Gudmundsson J; Sulem P; Stacey SN; Thorlacius S; Amundadottir L; Grönberg H; Xu J; Gaborieau V; Eeles RA; Neal DE; Donovan JL; Hamdy FC; Muir K; Hwang SJ; Spitz MR; Zanke B; Carvajal-Carmona L; Brown KM; ; Hayward NK; Macgregor S; Tomlinson IP; Lemire M; Amos CI; Murabito JM; Isaacs WB; Easton DF; Brennan P; ; Barkardottir RB; Gudbjartsson DF; Rafnar T; Hunter DJ; Chanock SJ; Stefansson K; Ioannidis JP
    PLoS One; 2010 May; 5(5):e10858. PubMed ID: 20526366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.
    Cardenas H; Vieth E; Lee J; Segar M; Liu Y; Nephew KP; Matei D
    Epigenetics; 2014 Nov; 9(11):1461-72. PubMed ID: 25470663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive germline-somatic interplay contributes to prostate cancer progression through HNF1B co-option of TMPRSS2-ERG.
    Giannareas N; Zhang Q; Yang X; Na R; Tian Y; Yang Y; Ruan X; Huang D; Yang X; Wang C; Zhang P; Manninen A; Wang L; Wei GH
    Nat Commun; 2022 Nov; 13(1):7320. PubMed ID: 36443337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression, Epigenetic, and Genetic Changes of HNF1B in Colorectal Lesions: an Analysis of 145 Cases.
    Bártů M; Hojný J; Hájková N; Michálková R; Krkavcová E; Simon K; Frýba V; Stružinská I; Němejcová K; Dundr P
    Pathol Oncol Res; 2020 Oct; 26(4):2337-2350. PubMed ID: 32488808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis.
    Grisanzio C; Werner L; Takeda D; Awoyemi BC; Pomerantz MM; Yamada H; Sooriakumaran P; Robinson BD; Leung R; Schinzel AC; Mills I; Ross-Adams H; Neal DE; Kido M; Yamamoto T; Petrozziello G; Stack EC; Lis R; Kantoff PW; Loda M; Sartor O; Egawa S; Tewari AK; Hahn WC; Freedman ML
    Proc Natl Acad Sci U S A; 2012 Jul; 109(28):11252-7. PubMed ID: 22730461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of prostate cancer risk variants rs10993994 and rs7098889 by CRISPR/Cas9 mediated genome editing.
    Wang X; Hayes JE; Xu X; Gao X; Mehta D; Lilja HG; Klein RJ
    Gene; 2021 Feb; 768():145265. PubMed ID: 33122083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.